Gilbert F J, Cordiner C M, Affleck I R, Hood D B, Mathieson D, Walker L G
Department of Radiology, University of Aberdeen Medical School, U.K.
Eur J Cancer. 1998 Dec;34(13):2010-4. doi: 10.1016/s0959-8049(98)00294-9.
The psychological effects of false-positive mammography were evaluated in 124 women who had taken part in the U.K. National Health Service Breast Screening Programme. In addition, the effects of recall on women with and without a family history were compared. These women were asked to complete the Hospital Anxiety and Depression Scale (HADS) before being invited to attend for screening, at recall and 5 weeks and 4 months after recall. At screening and at recall, the women were asked to complete the Health Questionnaire (HQ) which measures stress-related behaviour changes in the previous week. In the week before screening, compared with women who did not have a family history of breast cancer, women with a family history had lower scores on HADS depression and reported fewer stress-related behaviour changes. At recall, regardless of family history, the women were more likely to have borderline or clinically significant anxiety than at baseline or screening. Nevertheless, for most women, recall-induced anxiety was relatively transient (less than 5 weeks). Compared with women without a family history, women with a family history were more anxious 4 months after recall, although their anxiety scores tended to be lower (P < 0.06) than at baseline. A strength of the present study is that the initial baseline measure was uncontaminated by the screening process. Women who did not complete questionnaires at one or more of the subsequent time points scored higher on HADS depression at baseline, indicating that the results are likely to have underestimated the effects of recall. Screening appears to be less stressful for women with a family history than for those without a history. However, for both groups recall causes short term distress. Breast screening programmes should ensure that steps are taken to minimise the number of women who are recalled for unnecessary investigations.
对124名参与英国国家医疗服务体系乳腺癌筛查项目的女性进行了乳腺钼靶检查假阳性的心理影响评估。此外,还比较了召回对有家族病史和无家族病史女性的影响。这些女性在被邀请参加筛查前、召回时、召回后5周和4个月时被要求完成医院焦虑抑郁量表(HADS)。在筛查时和召回时,这些女性被要求完成健康问卷(HQ),该问卷测量前一周与压力相关的行为变化。在筛查前一周,与无乳腺癌家族病史的女性相比,有家族病史的女性在HADS抑郁量表上得分更低,且报告的与压力相关的行为变化更少。在召回时,无论家族病史如何,这些女性比基线或筛查时更有可能出现临界或具有临床意义的焦虑。然而,对大多数女性来说,召回引起的焦虑相对短暂(少于5周)。与无家族病史的女性相比,有家族病史的女性在召回后4个月时更焦虑,尽管她们的焦虑得分往往低于基线(P<0.06)。本研究的一个优点是初始基线测量未受筛查过程的影响。在一个或多个后续时间点未完成问卷的女性在基线时HADS抑郁量表得分更高,这表明结果可能低估了召回的影响。筛查对有家族病史的女性似乎比对无家族病史的女性压力更小。然而,对两组来说,召回都会引起短期困扰。乳腺癌筛查项目应确保采取措施尽量减少因不必要检查而被召回的女性人数。